Onderneming Sailong Pharmaceutical Group Co.,Ltd.
Aandelen
002898
CNE1000032S5
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,16 CNY | -1,45% | -2,31% | -27,27% |
19/04 | Sailong Pharmaceutical Group Co. Rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024 | CI |
08/04 | Sailong Pharmaceutical Group Co. Keurt bestuursverkiezingen goed | CI |
Vakgebied
Aantal werknemers: 483
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug
94,8
%
| 257 | 97,4 % | 294 | 94,8 % | +14,44% |
Beverages
2,4
%
| 2 | 0,7 % | 8 | 2,4 % | +331,70% |
Other Business
2,3
%
| 3 | 1,2 % | 7 | 2,3 % | +133,27% |
Commissioned Processing
0,3
%
| 0 | 0,2 % | 1 | 0,3 % | +118,59% |
Other
0,1
%
| 2 | 0,6 % | 0 | 0,1 % | -71,98% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 264 | 100,0 % | 311 | 100,0 % | +17,58% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chi Nong Cai
CEO | Chief Executive Officer | 51 | 03-04-02 |
Jing Gao
DFI | Director of Finance/CFO | 48 | 01-08-13 |
Jian Feng Li
CTO | Chief Tech/Sci/R&D Officer | 43 | 01-01-08 |
Xu Zhang
BRD | Director/Board Member | 38 | 01-01-08 |
Lin Tang
BRD | Director/Board Member | 50 | 01-01-05 |
Hai Yan Tan
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nan Gui Cai
FOU | Founder | 62 | 03-04-02 |
Chi Nong Cai
CEO | Chief Executive Officer | 51 | 03-04-02 |
Lin Tang
BRD | Director/Board Member | 50 | 01-01-05 |
Zhi Xiang Long
BRD | Director/Board Member | 62 | - |
Jian Feng Li
CTO | Chief Tech/Sci/R&D Officer | 43 | 01-01-08 |
Zi Qiang Yuan
BRD | Director/Board Member | 54 | 20-08-15 |
Da Wen Liu
CHM | Chairman | 35 | 01-01-10 |
Bei Zhou
BRD | Director/Board Member | 54 | - |
Yong Jun Deng
BRD | Director/Board Member | 51 | - |
Wei Zhang
BRD | Director/Board Member | 51 | 08-12-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 176 000 000 | 59 684 065 ( 33,91 %) | 0 | 33,91 % |
Bedrijfsgegevens
Sailong Pharmaceutical Group Co., Ltd.
West Wing, 2/F Everbright International Trade Ctr
519015, Zhuhai
+86 75 6388 2955
http://www.sailong.cnSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,27% | 247 mln. | |
+20,08% | 22,46 mld. | |
+18,18% | 15,04 mld. | |
+18,94% | 13,98 mld. | |
+56,80% | 13,15 mld. | |
-10,55% | 6,89 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+14,03% | 5,71 mld. | |
+6,11% | 4,69 mld. |
- Beurs
- Aandelen
- Koers 002898
- Onderneming Sailong Pharmaceutical Group Co.,Ltd.